Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet…

By G. Patti, G. Colonna, V. Pasceri, L. Pepe, A. Montinaro, G. Di Sciascio. Circulation, 2005

685 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/59a6ba96e41fd6e9b42115f7d2ce6e068a3ada68

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rick A. Nishimura
2. J. Halperin

Citations in the corpus

• Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study (2006, neutral): “... (100) 1 Distal anastomoses 2.30.7 2.40.8 0.32 CPB duration, min 10530 11337 0.09 Cross-clamp duration, min 7327 7634 0.9 Blood cardioplegia 99 (100) 101 (100) 1 Atrial or atrioventricular pacing 2 (2) 2 (2) 1 Bicaval cannulation 7 (7) 2 (2) 0.10 Pulmonary vein venting 23 (23) 14 (14) 0.13 Postop”
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006, background): “The best evidence of efficacy exists for 300 mg given at least 6 hours before PCI is performed (68,69,72).”